8-K: Versus Systems Faces Nasdaq Listing Deficiency

Versus Systems received a deficiency letter from Nasdaq for failing to meet the minimum stockholders' equity requirement, with a plan to regain compliance due by June 13, 2026.

Summary

• Versus Systems Inc. received a deficiency letter from The Nasdaq Stock Market on April 29, 2026.
• The deficiency is due to not maintaining the required minimum of $2,500,000 in stockholders' equity as of December 31, 2025.
• As of December 31, 2025, the company's stockholders' equity was $1,918,303.
• The company does not currently meet alternative listing requirements for market value of listed securities or net income from continuing operations.
• Nasdaq has given the company 45 days, until June 13, 2026, to submit a plan to regain compliance.
• If the plan is accepted, Nasdaq may grant an extension until October 26, 2026, to achieve compliance.
• As part of the compliance plan, the company entered into a Stock Purchase Agreement (SPA) with ASPIS Cyber Technologies, Inc. (ASPIS) on April 15, 2026.
• Under the SPA, Versus Systems will sell 1,513,128 shares of common stock to ASPIS for $1,700,000, at a price of $1.1235 per share.
• The closing of this stock sale is expected on or before May 14, 2026.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a negative development due to the Nasdaq listing deficiency, but the proactive steps to address it with a capital raise provide some mitigation.

Positives

• The company has a plan in place to regain compliance with Nasdaq listing requirements.
• A stock purchase agreement with ASPIS Cyber Technologies, Inc. for $1.7 million has been executed, which is expected to improve equity.
• The purchase price per share in the SPA is at a premium (105% of the closing price on April 14, 2026).

Negatives

• The company is currently not in compliance with Nasdaq's minimum stockholders' equity requirement of $2,500,000.
• As of December 31, 2025, stockholders' equity was $1,918,303, falling short of the requirement.
• The company does not meet alternative Nasdaq listing criteria related to market value of listed securities or net income from continuing operations.

Risks

• Failure to submit an acceptable plan to Nasdaq by June 13, 2026, could lead to delisting.
• If the plan is not accepted or compliance is not achieved by October 26, 2026, the company's securities may be delisted from Nasdaq.
• The stock sale to ASPIS is contingent on closing by May 14, 2026, and any delay or failure to close could jeopardize the equity improvement plan.

Future Outlook

The company is focused on regaining compliance with Nasdaq's minimum stockholders' equity requirement by submitting a plan and completing a stock sale to ASPIS Cyber Technologies, Inc. by mid-May 2026. If successful, they may have until October 26, 2026, to fully comply.

Industry Context

StockSavvy.ai notes that Nasdaq listing deficiencies are common for companies facing financial challenges. The ability to secure a capital raise, especially at a premium, is crucial for maintaining exchange listing and investor confidence.

Stakeholder Impact

• Shareholders: Potential delisting from Nasdaq could negatively impact share liquidity and valuation. The capital raise dilutes existing shareholders but is necessary for continued listing.
• Creditors: Continued listing on Nasdaq may be important for maintaining creditworthiness.
• Employees: Uncertainty around listing status could impact morale and future company stability.

Next Steps

• Submit a plan to Nasdaq to regain compliance with stockholders' equity requirement by June 13, 2026.
• Close the stock sale with ASPIS Cyber Technologies, Inc. by May 14, 2026.
• Regain compliance with Nasdaq's minimum stockholders' equity requirement by October 26, 2026, if the plan is accepted.

Key Dates

Recommendation

The company is facing a significant Nasdaq listing deficiency, which poses a risk of delisting. While a capital raise is underway to address this, the outcome is not guaranteed, and the company's financial health remains a concern. A 'hold' recommendation reflects the uncertainty and the need to monitor the company's progress in regaining compliance.

Keywords

Nasdaq Listing Deficiency, Stockholders Equity, Versus Systems, ASPIS Cyber Technologies, Form 8-K, Compliance Plan, Delisting Risk, Capital Raise